JOHNPHARMADiversified Commercial Services
Johnson Pharmacare Ltd — Profit & Loss Statement
₹0.48
-4.00%
Johnson Pharmacare Ltd Profit & Loss Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Tax Effect Of Unusual Items | 0.00 | 0.00 | -0.04 Cr | 0.00 | — |
| Tax Rate For Calcs | 0.00 | 0.00 | 0.03 | 0.28 | — |
| Normalized EBITDA | -0.41 Cr | -0.20 Cr | 0.22 Cr | 0.13 Cr | — |
| Total Unusual Items | -0.17 Cr | 0.00 | -1.55 Cr | 0.00 | — |
| Total Unusual Items Excluding Goodwill | -0.17 Cr | 0.00 | -1.55 Cr | 0.00 | — |
| Net Income From Continuing Operation Net Minority Interest | -0.58 Cr | -0.20 Cr | -1.29 Cr | 0.10 Cr | — |
| Reconciled Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Reconciled Cost Of Revenue | 90000.00 | 0.00 | 2.09 Cr | 2.79 Cr | — |
| EBITDA | -0.58 Cr | -0.20 Cr | -1.33 Cr | 0.13 Cr | — |
| EBIT | -0.58 Cr | -0.20 Cr | -1.33 Cr | 0.13 Cr | — |
| Net Interest Income | 0.00 | 0.00 | -8000.00 | -3000.00 | — |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Normalized Income | -0.41 Cr | -0.20 Cr | 0.22 Cr | 0.10 Cr | — |
| Net Income From Continuing And Discontinued Operation | -0.58 Cr | -0.20 Cr | -1.29 Cr | 0.10 Cr | — |
| Total Expenses | 0.08 Cr | 0.20 Cr | 2.30 Cr | 3.13 Cr | — |
| Diluted Average Shares | 58.38 Cr | 55.00 Cr | 55.00 Cr | 55.00 Cr | — |
| Basic Average Shares | 58.38 Cr | 55.00 Cr | 55.00 Cr | 55.00 Cr | — |
| Diluted EPS | -0.01 | 0.00 | -0.02 | 0.00 | — |
| Basic EPS | -0.01 | 0.00 | -0.02 | 0.00 | — |
| Diluted NI Availto Com Stockholders | -0.58 Cr | -0.20 Cr | -1.29 Cr | 0.10 Cr | — |
| Net Income Common Stockholders | -0.58 Cr | -0.20 Cr | -1.29 Cr | 0.10 Cr | — |
| Otherunder Preferred Stock Dividend | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income | -0.58 Cr | -0.20 Cr | -1.29 Cr | 0.10 Cr | — |
| Net Income Including Noncontrolling Interests | -0.58 Cr | -0.20 Cr | -1.29 Cr | 0.10 Cr | — |
| Net Income Continuous Operations | -0.58 Cr | -0.20 Cr | -1.29 Cr | 0.10 Cr | — |
| Tax Provision | 0.00 | 0.00 | -0.04 Cr | 0.04 Cr | — |
| Pretax Income | -0.58 Cr | -0.20 Cr | -1.33 Cr | 0.13 Cr | — |
| Other Non Operating Income Expenses | -0.33 Cr | — | -1.51 Cr | — | — |
| Special Income Charges | -0.17 Cr | 0.00 | 0.00 | 0.00 | — |
| Net Non Operating Interest Income Expense | 0.00 | 0.00 | -8000.00 | -3000.00 | — |
| Interest Expense Non Operating | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Operating Income | -0.08 Cr | -0.20 Cr | 0.22 Cr | 0.13 Cr | — |
| Operating Expense | 0.07 Cr | 0.20 Cr | 0.21 Cr | 0.34 Cr | — |
| Other Operating Expenses | 0.07 Cr | 0.20 Cr | 0.19 Cr | 0.29 Cr | — |
| Depreciation And Amortization In Income Statement | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Depreciation Income Statement | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Gross Profit | -90000.00 | 0.00 | 0.43 Cr | 0.48 Cr | — |
| Cost Of Revenue | 90000.00 | 0.00 | 2.09 Cr | 2.79 Cr | — |
| Total Revenue | 0.00 | 0.00 | 2.53 Cr | 3.26 Cr | — |
| Operating Revenue | 0.00 | 0.00 | 2.53 Cr | 3.26 Cr | — |
| Rent Expense Supplemental | — | 55000.00 | 27000.00 | 0.03 Cr | 0.00 |
| Total Other Finance Cost | — | 9000.00 | 8000.00 | 3000.00 | — |
| Selling General And Administration | — | 18000.00 | 0.01 Cr | 0.02 Cr | 10000.00 |
| General And Administrative Expense | — | 18000.00 | 0.01 Cr | 0.02 Cr | 10000.00 |
| Rent And Landing Fees | — | 55000.00 | 27000.00 | 0.03 Cr | 0.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Johnson Pharmacare Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.